Novel spectrometry Market Report 2026

Novel spectrometry Market Overview

• Novel spectrometry market size has reached to $4.76 billion in 2025 • Expected to grow to $6.97 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: ising Demand For Personalized Medicine Fuels Growth In The Novel Spectrometry Market • Market Trend: Advancing Chromatography-Free Analysis With Novel Triple-Quadrupole Mass Spectrometry • North America was the largest region in 2025.

What Is Covered Under Novel spectrometry Market?

Novel spectrometry refers to innovative or advanced techniques in the field of spectrometry, which is the study of the interaction between light and matter. These novel methods often involve new approaches, technologies, or instruments that enhance the ability to analyze and measure the properties of substances. The main types of spectrometers in novel spectrometry are atomic absorption spectrometers, mass spectrometers, near-infrared spectrometers, nuclear magnetic resonance spectrometers, raman spectrometers, and X-ray fluorescence spectrometers. An atomic absorption spectrometer is an analytical device that measures the concentration of elements by detecting the light absorbed by vaporized samples. These spectrometers are suitable for companies of all sizes, including small, mid-sized, and large, and serve various end-users, such as agriculture and pesticide testing, environmental analysis, food biotechnology, forensic analysis, pharmaceutical analysis, and others.

What Is The Novel spectrometry Market Growth Forecast?

The novel spectrometry market size is expected to see strong growth in the next few years. It will grow to $6.97 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to automation of analytical laboratories, demand for portable spectrometry devices, growth of personalized medicine research, expansion of industrial process analytics, increased funding for advanced material science. Major trends in the forecast period include AI-enhanced spectral data interpretation, smart factory integration of spectrometry systems, connected and remote spectrometry platforms, cloud-based spectral data management, precision medicine-driven analytical spectrometry.

Global Novel spectrometry Market Segmentation

1) By Type Of Spectrometers: Atomic Absorption Spectrometer, Mass Spectrometer, Near Infrared Spectrometer, Nuclear Magnetic Resonance Spectrometer, Raman Spectrometer, X-Ray Fluorescence Spectrometer 2) By Company Size: Small, Mid-Sized, Large 3) By End-User: Agriculture Or Pesticide Testing, Environmental Analysis, Food Biotechnology, Forensic Analysis, Pharmaceutical Analysis, Other End Users Subsegments: 1) By Atomic Absorption Spectrometer: Flame Atomic Absorption Spectrometers (FAAS), Graphite Furnace Atomic Absorption Spectrometers (GFAAS), Hydride Generation Atomic Absorption Spectrometers 2) By Mass Spectrometer: Quadrupole Mass Spectrometers, Time-Of-Flight Mass Spectrometers (TOF-MS), Ion Trap Mass Spectrometers, Orbitrap Mass Spectrometers 3) By Near Infrared Spectrometer: Dispersive Near Infrared Spectrometers, Fourier Transform Near Infrared Spectrometers (FT-NIR), NIR Spectrometers for Industrial Applications 4) By Nuclear Magnetic Resonance Spectrometer: High-Field NMR Spectrometers, Low-Field NMR Spectrometers, Portable NMR Spectrometers 5) By Raman Spectrometer: Dispersive Raman Spectrometers, FT-Raman Spectrometers, Portable Raman Spectrometers 6) By X-Ray Fluorescence Spectrometer: Energy Dispersive X-Ray Fluorescence (EDXRF) Spectrometers, Wavelength Dispersive X-Ray Fluorescence (WDXRF) Spectrometers, Portable X-Ray Fluorescence Spectrometers

What Is The Driver Of The Novel spectrometry Market?

Increasing demand for personalized medicine is expected to propel the growth of the novel spectrometry market going forward. Personalized medicine refers to a medical approach that tailors treatments and healthcare strategies to individual patients based on their unique genetic, environmental, and lifestyle factors. Demand for personalized medicine is rising due to advancements in genomics, which allow for more precise treatments and improved patient outcomes, as tailored therapies lead to more effective and targeted interventions. Novel spectrometry drives demand for personalized medicine by enabling precise biomarker analysis and tailored treatment plans, improving the accuracy and effectiveness of individualized therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the U.S. Food and Drug Administration (FDA) approved 16 new personalized treatments for rare diseases in 2023, a significant increase from the 6 approvals granted in 2022. Therefore, increasing demand for personalized medicine is driving the growth of the novel spectrometry industry.

Key Players In The Global Novel spectrometry Market

Major companies operating in the novel spectrometry market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Teledyne Photon Instruments, PerkinElmer Inc., LECO Corporation, Endress+Hauser Group, Shimadzu Corporation, Waters Corporation, Bruker Corporation, Horiba Ltd., FLIR Systems Inc., Sciex, JEOL Ltd., Oxford Instruments plc, Rigaku Corporation, Peak Scientific Instruments Ltd., Nanalysis Corp., Scion Instruments, Hiden Analytical Ltd., Labman Automation Ltd., Advion Inc., Exciton Inc., SRI Instruments

Global Novel spectrometry Market Trends and Insights

Major companies operating in the novel spectrometry market are focusing on developing technologically advanced spectroscopy solutions, such as novel triple-quadrupole mass spectrometers, to enhance analytical capabilities and improve sensitivity and accuracy in complex sample analysis. Novel triple-quadrupole mass spectrometers refer to advanced versions of triple-quadrupole mass spectrometers, which are designed to provide enhanced performance for quantitative and qualitative analysis. For instance, in June 2023, Bruker Corporation, a US-based manufacturer of scientific instruments, introduced the EVOQ DART-TQ+, a novel triple-quadrupole mass spectrometer designed for chromatography-free mass spectrometry, aimed at applied market segments such as food and beverage, forensic toxicology, industrial, and environmental analysis. The system integrates a fully integrated direct analysis in real time (DART) ionization technique source, allowing for simplified and efficient routine analysis without the need for complex gas or liquid chromatography while also addressing the demand for cost-effective and environmentally sustainable workflows.

What Are Latest Mergers And Acquisitions In The Novel spectrometry Market?

In June 2023, Thermo Fisher Scientific, a US-based life science and clinical research company, acquired MarqMetrix, Inc., for an undisclosed amount. With this acquisition, Thermo Fisher Scientific’s aim was to strategically enhance its Raman spectroscopy portfolio by adding MarqMetrix’s complementary, innovative in-line Process Analytical Technology (PAT). MarqMetrix is a US-based company that provides technology considered to be novel process Raman spectrometry solutions.

Regional Outlook

North America was the largest region in the novel spectrometry market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Novel spectrometry Market?

The novel spectrometry market includes revenues earned by entities by providing services such as environmental monitoring, trace analysis, high-resolution analysis, and biological and medical diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The novel spectrometry market also consists of sales of portable spectrometers, advanced spectrometers, multimodal spectroscopy systems, and enhanced data processing software. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.